Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Pilotto

Showing results (271-280 of 288) with videos related to

Pageof 29
Sort By:
BMC Primary Care|October 28, 2025
Usefulness of the BRIEF-Multidimensional Prognostic Index (BRIEF-MPI) to identify older adults' healthcare needs to be addressed with a Personalized Prevention Program in general practice: preliminary data from the PrimaCare_P3 studyAlberto Pilotto, Wanda Morganti, Emanuele Seminerio, et al.
Journal of the American Medical Directors Association|August 7, 2022
Can the Multidimensional Prognostic Index Improve the Identification of Older Hospitalized Patients with COVID-19 Likely to Benefit from Mechanical Ventilation? An Observational, Prospective, Multicenter StudyAlberto Pilotto, Eva Topinkova, Helena Michalkova, et al.
Aging Clinical and Experimental Research|February 22, 2025
Musculoskeletal diseases, infections and vaccines: state of the art, research perspectives and educational needsFiona Ecarnot, Jotheeswaran Amuthavalli Thiyagarajan, Mario Barbagallo, et al.
Drugs & Aging|June 13, 2023
The Role of Multidimensional Prognostic Index to Identify Hospitalized Older Adults with COVID-19 Who Can Benefit from Remdesivir Treatment: An Observational, Prospective, Multicenter StudyCarlo Custodero, Nicola Veronese, Eva Topinkova, et al.
European Geriatric Medicine|June 15, 2024
The Multidimensional Prognostic Index predicts incident delirium among hospitalized older patients with COVID-19: a multicenter prospective European studyWanda Morganti, Carlo Custodero, Nicola Veronese, et al.
Journal of Clinical Medicine|August 27, 2021
Multidimensional Prognostic Index and Outcomes in Older Patients Undergoing Transcatheter Aortic Valve Implantation: Survival of the FittestJeannette A Goudzwaard, Sadhna Chotkan, Marjo J A G De Ronde-Tillmans, et al.
Aging Clinical and Experimental Research|January 1, 2016
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaJean-Yves Reginster, Cyrus Cooper, René Rizzoli, et al.
Aging Clinical and Experimental Research|February 7, 2020
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patientsMaria Cristina Ferrara, Anita Andreano, Elena Tassistro, et al.
Neurobiology of Aging|January 12, 2011
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populationsJean-Charles Lambert, Diana Zelenika, Mikko Hiltunen, et al.
European Journal of Clinical Pharmacology|August 10, 2020
Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trialsFarhad Pazan, Mirko Petrovic, Antonio Cherubini, et al.
Pageof 29

Showing results (271-280 of 288) with videos related to

Sort By:
Pageof 29
BMC Primary Care|October 28, 2025
Usefulness of the BRIEF-Multidimensional Prognostic Index (BRIEF-MPI) to identify older adults' healthcare needs to be addressed with a Personalized Prevention Program in general practice: preliminary data from the PrimaCare_P3 studyAlberto Pilotto, Wanda Morganti, Emanuele Seminerio, et al.
Journal of the American Medical Directors Association|August 7, 2022
Can the Multidimensional Prognostic Index Improve the Identification of Older Hospitalized Patients with COVID-19 Likely to Benefit from Mechanical Ventilation? An Observational, Prospective, Multicenter StudyAlberto Pilotto, Eva Topinkova, Helena Michalkova, et al.
Aging Clinical and Experimental Research|February 22, 2025
Musculoskeletal diseases, infections and vaccines: state of the art, research perspectives and educational needsFiona Ecarnot, Jotheeswaran Amuthavalli Thiyagarajan, Mario Barbagallo, et al.
Drugs & Aging|June 13, 2023
The Role of Multidimensional Prognostic Index to Identify Hospitalized Older Adults with COVID-19 Who Can Benefit from Remdesivir Treatment: An Observational, Prospective, Multicenter StudyCarlo Custodero, Nicola Veronese, Eva Topinkova, et al.
European Geriatric Medicine|June 15, 2024
The Multidimensional Prognostic Index predicts incident delirium among hospitalized older patients with COVID-19: a multicenter prospective European studyWanda Morganti, Carlo Custodero, Nicola Veronese, et al.
Journal of Clinical Medicine|August 27, 2021
Multidimensional Prognostic Index and Outcomes in Older Patients Undergoing Transcatheter Aortic Valve Implantation: Survival of the FittestJeannette A Goudzwaard, Sadhna Chotkan, Marjo J A G De Ronde-Tillmans, et al.
Aging Clinical and Experimental Research|January 1, 2016
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaJean-Yves Reginster, Cyrus Cooper, René Rizzoli, et al.
Aging Clinical and Experimental Research|February 7, 2020
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patientsMaria Cristina Ferrara, Anita Andreano, Elena Tassistro, et al.
Neurobiology of Aging|January 12, 2011
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populationsJean-Charles Lambert, Diana Zelenika, Mikko Hiltunen, et al.
European Journal of Clinical Pharmacology|August 10, 2020
Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trialsFarhad Pazan, Mirko Petrovic, Antonio Cherubini, et al.
Pageof 29